Loading…

Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest

While many antibody therapeutics are formulated at low concentration (~10-20 mg/mL) for intravenous administration, high concentration (> 100 mg/mL) formulations may be required for subcutaneous delivery in certain clinical indications. For such high concentration formulations, product color is m...

Full description

Saved in:
Bibliographic Details
Published in:mAbs 2014-05, Vol.6 (3), p.679-688
Main Authors: Derfus, Gayle E, Dizon-Maspat, Jemelle, Broddrick, Jared T, Velayo, Arleene C, Toschi, Josh D, Santuray, Rodell T, Hsu, Stephen K, Winter, Charles M, Krishnan, Rajesh, Amanullah, Ashraf
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2697-5598b612d91cbac49158b18274a5ca313767cceb08d4d7444118cb007e0d964e3
cites cdi_FETCH-LOGICAL-c2697-5598b612d91cbac49158b18274a5ca313767cceb08d4d7444118cb007e0d964e3
container_end_page 688
container_issue 3
container_start_page 679
container_title mAbs
container_volume 6
creator Derfus, Gayle E
Dizon-Maspat, Jemelle
Broddrick, Jared T
Velayo, Arleene C
Toschi, Josh D
Santuray, Rodell T
Hsu, Stephen K
Winter, Charles M
Krishnan, Rajesh
Amanullah, Ashraf
description While many antibody therapeutics are formulated at low concentration (~10-20 mg/mL) for intravenous administration, high concentration (> 100 mg/mL) formulations may be required for subcutaneous delivery in certain clinical indications. For such high concentration formulations, product color is more apparent due to the higher molecular density across a given path-length. Color is therefore a product quality attribute that must be well-understood and controlled, to demonstrate process consistency and enable clinical trial blinding. Upon concentration of an IgG4 product at the 2000 L manufacturing scale, variability in product color, ranging from yellow to red, was observed. A small-scale experimental model was developed to assess the effect of processing conditions (medium composition and harvest conditions) on final bulk drug substance (BDS) color. The model was used to demonstrate that, for two distinct IgG4 products, red coloration occurred only in the presence of disulfide reduction-mediated antibody dissociation. The red color-causing component was identified as vitamin B 12 , in the hydroxocobalamin form, and the extent of red color was correlated with the cobalt (vitamin B 12 ) concentration in the final pools. The intensity of redness in the final BDS was modulated by changing the concentration of vitamin B 12 in the cell culture media.
doi_str_mv 10.4161/mabs.28257
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4011912</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1516722484</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2697-5598b612d91cbac49158b18274a5ca313767cceb08d4d7444118cb007e0d964e3</originalsourceid><addsrcrecordid>eNptkVtLJDEQhcOyyyrqy_6AJY-yMJrKJJ3uF0HFGwjCsvscKpd2ot0dN-kemX9vxtFhBeulCvLVySkOIT-AHQmo4LhHk494zaX6QnahEXzGasW-bueK75CDnB_YuhQDxb6THS6k5FXDdsnjb--ojV1Mpd_cXwlqccplNiu6DCP2YaBnwGmbYk-t7zpqp26ckqe9dwHLam_CUPjnMC6oC3nq2uA8LXKTHUMcKI50gWnp87hPvrXYZX_w1vfI38uLP-fXs9u7q5vz09uZLZ7UTMqmNhVw14A1aEUDsjZQcyVQWpzDXFXKWm9Y7YRTQgiA2ppynGeuqYSf75GTje7TZIpL64cxYaefUugxrXTEoD--DGGh7-NSCwbQAC8Ch28CKf6binPdh7w-Hgcfp6xBQqU4F7Uo6K8NalPMOfl2-w0wvQ5IrwPSrwEV-Of_xrboexwFkBsgDG1MPT7H1Dk94qrk0yYcbMh6_onwC-Wgnrw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1516722484</pqid></control><display><type>article</type><title>Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest</title><source>PubMed Central</source><creator>Derfus, Gayle E ; Dizon-Maspat, Jemelle ; Broddrick, Jared T ; Velayo, Arleene C ; Toschi, Josh D ; Santuray, Rodell T ; Hsu, Stephen K ; Winter, Charles M ; Krishnan, Rajesh ; Amanullah, Ashraf</creator><creatorcontrib>Derfus, Gayle E ; Dizon-Maspat, Jemelle ; Broddrick, Jared T ; Velayo, Arleene C ; Toschi, Josh D ; Santuray, Rodell T ; Hsu, Stephen K ; Winter, Charles M ; Krishnan, Rajesh ; Amanullah, Ashraf</creatorcontrib><description>While many antibody therapeutics are formulated at low concentration (~10-20 mg/mL) for intravenous administration, high concentration (&gt; 100 mg/mL) formulations may be required for subcutaneous delivery in certain clinical indications. For such high concentration formulations, product color is more apparent due to the higher molecular density across a given path-length. Color is therefore a product quality attribute that must be well-understood and controlled, to demonstrate process consistency and enable clinical trial blinding. Upon concentration of an IgG4 product at the 2000 L manufacturing scale, variability in product color, ranging from yellow to red, was observed. A small-scale experimental model was developed to assess the effect of processing conditions (medium composition and harvest conditions) on final bulk drug substance (BDS) color. The model was used to demonstrate that, for two distinct IgG4 products, red coloration occurred only in the presence of disulfide reduction-mediated antibody dissociation. The red color-causing component was identified as vitamin B 12 , in the hydroxocobalamin form, and the extent of red color was correlated with the cobalt (vitamin B 12 ) concentration in the final pools. The intensity of redness in the final BDS was modulated by changing the concentration of vitamin B 12 in the cell culture media.</description><identifier>ISSN: 1942-0862</identifier><identifier>ISSN: 1942-0870</identifier><identifier>EISSN: 1942-0870</identifier><identifier>EISSN: 1942-0862</identifier><identifier>DOI: 10.4161/mabs.28257</identifier><identifier>PMID: 24552690</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Animals ; Antibodies, Monoclonal - administration &amp; dosage ; Antibodies, Monoclonal - chemistry ; Antibodies, Monoclonal - isolation &amp; purification ; bioprocess ; Chemistry, Pharmaceutical ; Chinese hamster ovary ; CHO Cells ; Cobalt - chemistry ; Color ; Colorimetry ; Cricetulus ; Culture Media - chemistry ; Disulfides - chemistry ; high concentration ; Humans ; Immunoglobulin G - administration &amp; dosage ; Immunoglobulin G - chemistry ; Immunoglobulin G - isolation &amp; purification ; Light ; monoclonal antibody ; Oxidation-Reduction ; Vitamin B 12 - chemistry</subject><ispartof>mAbs, 2014-05, Vol.6 (3), p.679-688</ispartof><rights>Copyright © 2014 Landes Bioscience 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2697-5598b612d91cbac49158b18274a5ca313767cceb08d4d7444118cb007e0d964e3</citedby><cites>FETCH-LOGICAL-c2697-5598b612d91cbac49158b18274a5ca313767cceb08d4d7444118cb007e0d964e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011912/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011912/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24552690$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Derfus, Gayle E</creatorcontrib><creatorcontrib>Dizon-Maspat, Jemelle</creatorcontrib><creatorcontrib>Broddrick, Jared T</creatorcontrib><creatorcontrib>Velayo, Arleene C</creatorcontrib><creatorcontrib>Toschi, Josh D</creatorcontrib><creatorcontrib>Santuray, Rodell T</creatorcontrib><creatorcontrib>Hsu, Stephen K</creatorcontrib><creatorcontrib>Winter, Charles M</creatorcontrib><creatorcontrib>Krishnan, Rajesh</creatorcontrib><creatorcontrib>Amanullah, Ashraf</creatorcontrib><title>Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest</title><title>mAbs</title><addtitle>MAbs</addtitle><description>While many antibody therapeutics are formulated at low concentration (~10-20 mg/mL) for intravenous administration, high concentration (&gt; 100 mg/mL) formulations may be required for subcutaneous delivery in certain clinical indications. For such high concentration formulations, product color is more apparent due to the higher molecular density across a given path-length. Color is therefore a product quality attribute that must be well-understood and controlled, to demonstrate process consistency and enable clinical trial blinding. Upon concentration of an IgG4 product at the 2000 L manufacturing scale, variability in product color, ranging from yellow to red, was observed. A small-scale experimental model was developed to assess the effect of processing conditions (medium composition and harvest conditions) on final bulk drug substance (BDS) color. The model was used to demonstrate that, for two distinct IgG4 products, red coloration occurred only in the presence of disulfide reduction-mediated antibody dissociation. The red color-causing component was identified as vitamin B 12 , in the hydroxocobalamin form, and the extent of red color was correlated with the cobalt (vitamin B 12 ) concentration in the final pools. The intensity of redness in the final BDS was modulated by changing the concentration of vitamin B 12 in the cell culture media.</description><subject>Animals</subject><subject>Antibodies, Monoclonal - administration &amp; dosage</subject><subject>Antibodies, Monoclonal - chemistry</subject><subject>Antibodies, Monoclonal - isolation &amp; purification</subject><subject>bioprocess</subject><subject>Chemistry, Pharmaceutical</subject><subject>Chinese hamster ovary</subject><subject>CHO Cells</subject><subject>Cobalt - chemistry</subject><subject>Color</subject><subject>Colorimetry</subject><subject>Cricetulus</subject><subject>Culture Media - chemistry</subject><subject>Disulfides - chemistry</subject><subject>high concentration</subject><subject>Humans</subject><subject>Immunoglobulin G - administration &amp; dosage</subject><subject>Immunoglobulin G - chemistry</subject><subject>Immunoglobulin G - isolation &amp; purification</subject><subject>Light</subject><subject>monoclonal antibody</subject><subject>Oxidation-Reduction</subject><subject>Vitamin B 12 - chemistry</subject><issn>1942-0862</issn><issn>1942-0870</issn><issn>1942-0870</issn><issn>1942-0862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><recordid>eNptkVtLJDEQhcOyyyrqy_6AJY-yMJrKJJ3uF0HFGwjCsvscKpd2ot0dN-kemX9vxtFhBeulCvLVySkOIT-AHQmo4LhHk494zaX6QnahEXzGasW-bueK75CDnB_YuhQDxb6THS6k5FXDdsnjb--ojV1Mpd_cXwlqccplNiu6DCP2YaBnwGmbYk-t7zpqp26ckqe9dwHLam_CUPjnMC6oC3nq2uA8LXKTHUMcKI50gWnp87hPvrXYZX_w1vfI38uLP-fXs9u7q5vz09uZLZ7UTMqmNhVw14A1aEUDsjZQcyVQWpzDXFXKWm9Y7YRTQgiA2ppynGeuqYSf75GTje7TZIpL64cxYaefUugxrXTEoD--DGGh7-NSCwbQAC8Ch28CKf6binPdh7w-Hgcfp6xBQqU4F7Uo6K8NalPMOfl2-w0wvQ5IrwPSrwEV-Of_xrboexwFkBsgDG1MPT7H1Dk94qrk0yYcbMh6_onwC-Wgnrw</recordid><startdate>201405</startdate><enddate>201405</enddate><creator>Derfus, Gayle E</creator><creator>Dizon-Maspat, Jemelle</creator><creator>Broddrick, Jared T</creator><creator>Velayo, Arleene C</creator><creator>Toschi, Josh D</creator><creator>Santuray, Rodell T</creator><creator>Hsu, Stephen K</creator><creator>Winter, Charles M</creator><creator>Krishnan, Rajesh</creator><creator>Amanullah, Ashraf</creator><general>Taylor &amp; Francis</general><general>Landes Bioscience</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201405</creationdate><title>Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest</title><author>Derfus, Gayle E ; Dizon-Maspat, Jemelle ; Broddrick, Jared T ; Velayo, Arleene C ; Toschi, Josh D ; Santuray, Rodell T ; Hsu, Stephen K ; Winter, Charles M ; Krishnan, Rajesh ; Amanullah, Ashraf</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2697-5598b612d91cbac49158b18274a5ca313767cceb08d4d7444118cb007e0d964e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - administration &amp; dosage</topic><topic>Antibodies, Monoclonal - chemistry</topic><topic>Antibodies, Monoclonal - isolation &amp; purification</topic><topic>bioprocess</topic><topic>Chemistry, Pharmaceutical</topic><topic>Chinese hamster ovary</topic><topic>CHO Cells</topic><topic>Cobalt - chemistry</topic><topic>Color</topic><topic>Colorimetry</topic><topic>Cricetulus</topic><topic>Culture Media - chemistry</topic><topic>Disulfides - chemistry</topic><topic>high concentration</topic><topic>Humans</topic><topic>Immunoglobulin G - administration &amp; dosage</topic><topic>Immunoglobulin G - chemistry</topic><topic>Immunoglobulin G - isolation &amp; purification</topic><topic>Light</topic><topic>monoclonal antibody</topic><topic>Oxidation-Reduction</topic><topic>Vitamin B 12 - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Derfus, Gayle E</creatorcontrib><creatorcontrib>Dizon-Maspat, Jemelle</creatorcontrib><creatorcontrib>Broddrick, Jared T</creatorcontrib><creatorcontrib>Velayo, Arleene C</creatorcontrib><creatorcontrib>Toschi, Josh D</creatorcontrib><creatorcontrib>Santuray, Rodell T</creatorcontrib><creatorcontrib>Hsu, Stephen K</creatorcontrib><creatorcontrib>Winter, Charles M</creatorcontrib><creatorcontrib>Krishnan, Rajesh</creatorcontrib><creatorcontrib>Amanullah, Ashraf</creatorcontrib><collection>Taylor &amp; Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>mAbs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Derfus, Gayle E</au><au>Dizon-Maspat, Jemelle</au><au>Broddrick, Jared T</au><au>Velayo, Arleene C</au><au>Toschi, Josh D</au><au>Santuray, Rodell T</au><au>Hsu, Stephen K</au><au>Winter, Charles M</au><au>Krishnan, Rajesh</au><au>Amanullah, Ashraf</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest</atitle><jtitle>mAbs</jtitle><addtitle>MAbs</addtitle><date>2014-05</date><risdate>2014</risdate><volume>6</volume><issue>3</issue><spage>679</spage><epage>688</epage><pages>679-688</pages><issn>1942-0862</issn><issn>1942-0870</issn><eissn>1942-0870</eissn><eissn>1942-0862</eissn><abstract>While many antibody therapeutics are formulated at low concentration (~10-20 mg/mL) for intravenous administration, high concentration (&gt; 100 mg/mL) formulations may be required for subcutaneous delivery in certain clinical indications. For such high concentration formulations, product color is more apparent due to the higher molecular density across a given path-length. Color is therefore a product quality attribute that must be well-understood and controlled, to demonstrate process consistency and enable clinical trial blinding. Upon concentration of an IgG4 product at the 2000 L manufacturing scale, variability in product color, ranging from yellow to red, was observed. A small-scale experimental model was developed to assess the effect of processing conditions (medium composition and harvest conditions) on final bulk drug substance (BDS) color. The model was used to demonstrate that, for two distinct IgG4 products, red coloration occurred only in the presence of disulfide reduction-mediated antibody dissociation. The red color-causing component was identified as vitamin B 12 , in the hydroxocobalamin form, and the extent of red color was correlated with the cobalt (vitamin B 12 ) concentration in the final pools. The intensity of redness in the final BDS was modulated by changing the concentration of vitamin B 12 in the cell culture media.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>24552690</pmid><doi>10.4161/mabs.28257</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1942-0862
ispartof mAbs, 2014-05, Vol.6 (3), p.679-688
issn 1942-0862
1942-0870
1942-0870
1942-0862
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4011912
source PubMed Central
subjects Animals
Antibodies, Monoclonal - administration & dosage
Antibodies, Monoclonal - chemistry
Antibodies, Monoclonal - isolation & purification
bioprocess
Chemistry, Pharmaceutical
Chinese hamster ovary
CHO Cells
Cobalt - chemistry
Color
Colorimetry
Cricetulus
Culture Media - chemistry
Disulfides - chemistry
high concentration
Humans
Immunoglobulin G - administration & dosage
Immunoglobulin G - chemistry
Immunoglobulin G - isolation & purification
Light
monoclonal antibody
Oxidation-Reduction
Vitamin B 12 - chemistry
title Red colored IgG4 caused by vitamin B12 from cell culture media combined with disulfide reduction at harvest
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A59%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Red%20colored%20IgG4%20caused%20by%20vitamin%20B12%20from%20cell%20culture%20media%20combined%20with%20disulfide%20reduction%20at%20harvest&rft.jtitle=mAbs&rft.au=Derfus,%20Gayle%20E&rft.date=2014-05&rft.volume=6&rft.issue=3&rft.spage=679&rft.epage=688&rft.pages=679-688&rft.issn=1942-0862&rft.eissn=1942-0870&rft_id=info:doi/10.4161/mabs.28257&rft_dat=%3Cproquest_pubme%3E1516722484%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2697-5598b612d91cbac49158b18274a5ca313767cceb08d4d7444118cb007e0d964e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1516722484&rft_id=info:pmid/24552690&rfr_iscdi=true